Study of NMS-1116354 in Advanced/Metastatic Solid Tumors
A Phase I Dose-Escalation Study of NMS-1116354 in Adult Patients With Advanced/Metastatic Solid Tumors
Sponsor: Nerviano Medical Sciences
Terminated
Discontinuation of clinical investigation with NMS-1116354
Other terminated trials from Nerviano Medical Sciences
Other Advanced/Metastatic Solid Tumors trials with similar outcome
A PHASE1 clinical study on Advanced/Metastatic Solid Tumors, this trial is terminated or withdrawn. The trial is conducted by Nerviano Medical Sciences and has accumulated 6 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE1
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nerviano Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .